NICOLE BROWN: Open Payments
NPI 1932534526 · CARRBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,532 in 81 payments from 15 companies in 2025. Trend: 2023 $1,147 · 2024 $1,257 · 2025 $1,532
Food & beverage: $1,532
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $437 |
| ABBVIE INC. | 22 | $380 |
| PFIZER INC. | 9 | $182 |
| Lilly USA, LLC | 15 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Abbott Laboratories | 1 | $32 |
| Exact Sciences Corporation | 1 | $27 |
Products named: Wegovy, VRAYLAR, NURTEC ODT, MOUNJARO, QULIPTA, EOHILIA, Ozempic, REXULTI.
Industry payments across NC — which companies pay providers there.
